Venetoclax retreatment after MRD- guided venetoclax plus /- ibrutinib: the improve study cohort

Scarfò, L; Heltai, S; Albi, E; Scarano, E; Schiattone, L; Farina, L; Moia, R; Deodato, M; Ferrario, A; Motta, M; Noto, A; Sancetta, R; Coscia, M; Rivela, P; Laurenti, L; Varettoni, M; Perotta, E; Capasso, A; Ranghetti, P; Ghia, P

LEUKEMIA & LYMPHOMA, 2023; 64 (): S86